Evaluation of neuro-muscular monitoring using the TetraGraph device

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034376

Enrollment

150

Registered

2024-06-18

Start date

2024-09-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient monitoring during general anesthesia.

Interventions

Group 1: Monitoring of the effect of neuro-muscular blocking agents during general anesthesia using the TertraGraph device (electromyography) and acceleromyography

in this study both monitring devices are used simultaneously on the same patient.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Consent. Neuromuscular blockade during general anesthesia required. Subgroups (arms not assessible, modified RSI, obesity).

Exclusion criteria

Exclusion criteria: Neuro-muscular disease. Emergency procedure. Pregnancy. Previous enrollment.

Design outcomes

Primary

Measure	Time frame
Time to train of four (TOF) count = 0	—

Secondary

Measure	Time frame
Time to defined TOF-counts and -ratios	—

Countries

Switzerland

Contacts

Public ContactAlexander Dullenkopf

Spital Thurgau Frauenfeld

alexander.dullenkopf@stgag.ch+41581447560

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026